Cells transduced ex vivo with transgenes encoded on retroviruses have constant and prolonged expression in vitro; however, in vivo expression is quickly lost. Much attention has been directed at methods to circumvent this problem. We have shown that loss of transgene expression does not occur when transduced immortalized 3T3 cells are transplanted to the in vivo setting of athymic mice. Ease of acquisition and potential for clinical application led us to assess the potential of using immortalized human keratinocytes for expression of transgenes in vivo. Human keratinocytes were immortalized with a HPV16-E6/E7 retrovirus, transduced with a lacZ retrovirus, cloned by limiting dilution, seeded onto a physiologic dermal substrate, A major hurdle for the clinical application of gene therapy is the fact that stable expression of the transgene is quickly lost in vivo. Previous studies in our laboratory, using normal human fibroblasts, were conducted to determine if loss of transgene expression in vivo resulted from cell loss. Cells were transduced with a retroviral vector encoding lacZ and cloned by limiting dilution. This protocol generated a uniform population of cells with the same genotype and phenotype, including identical insertion sites of the transgenes. The cloned, transduced cells were expanded in vitro in a collagen coated nylon matrix, transplanted to athymic mice, and followed for 16 wk in vivo. These studies demonstrated that loss of transgene expression in vivo was an organized event, most compatible with apoptotic events (Krueger et al, 1997) . Loss of transgene expression was linked to the age of the cells: senescent fibroblasts were lost more quickly in vivo than their nonsenescent counterparts (Krueger et al, 1997) . Importantly, immortalized fibroblasts (3T3 cells) transduced with retroviral vectors did not lose expression in vivo (Krueger et al, 1994; Petersen et al, 1995 not be studied in a similar fashion, because keratinocytes have a limited life span in culture (µ20 cell doublings) in the defined media we use and do not survive the rigors of cloning by limiting dilution (repeated unpublished observations from our laboratory, 1998). Thus, methods to extend the life span of cultured keratinocytes were examined. We chose to transduce keratinocytes with a retroviral vector encoding the E6/E7 genes of human papilloma virus, type 16 (HPV16) (Halbert et al, 1991 (Halbert et al, , 1992 . The HPV16-E6/E7 genes inactivate tumor suppressor genes p53 and Rb, thereby bypassing signals that normally lead to cell cycle arrest in G1 (Demers et al, 1996) . Transduction of keratinocytes with an HPV16-E6/E7 retroviral vector will immortalize normal human keratinocytes (IMKc) (Demers et al, 1996) . It has been reported that these IMKc form an epidermal structure with an altered morphology when grown on a collagen raft in vitro (Halbert et al, 1992) ; however, the morphology of an epidermis generated from and the expression of transgenes by HPV16-E6/E7 IMKc in vivo has not been studied.
and transplanted to athymic mice. Six weeks after transplantation, the immortalized transgene expressing keratinocytes had formed an epidermis that was indistinguishable from one formed by nonimmortalized keratinocytes; furthermore, there was no loss of expression of the lacZ gene. These observations show that methods to extend cell survival are an alternative approach to achieving stable and prolonged expression of transgenes in vivo and that HPV16-E6/ E7 immortalized keratinocytes generate an epidermis with normal morphology. Key words: genetically modified keratinocytes/gene therapy/E6/E7 transformed cells. J Invest Dermatol 112:233-239, 1999 not be studied in a similar fashion, because keratinocytes have a limited life span in culture (µ20 cell doublings) in the defined media we use and do not survive the rigors of cloning by limiting dilution (repeated unpublished observations from our laboratory, 1998). Thus, methods to extend the life span of cultured keratinocytes were examined. We chose to transduce keratinocytes with a retroviral vector encoding the E6/E7 genes of human papilloma virus, type 16 (HPV16) (Halbert et al, 1991 (Halbert et al, , 1992 . The HPV16-E6/E7 genes inactivate tumor suppressor genes p53 and Rb, thereby bypassing signals that normally lead to cell cycle arrest in G1 (Demers et al, 1996) . Transduction of keratinocytes with an HPV16-E6/E7 retroviral vector will immortalize normal human keratinocytes (IMKc) (Demers et al, 1996) . It has been reported that these IMKc form an epidermal structure with an altered morphology when grown on a collagen raft in vitro (Halbert et al, 1992) ; however, the morphology of an epidermis generated from and the expression of transgenes by HPV16-E6/E7 IMKc in vivo has not been studied.
The aims of these studies were to assess the expression of stably integrated transgenes in IMKc in vivo and to assess the morphology of the epidermis formed by IMKc in vivo. This was accomplished by introducing a second transgene (lacZ encoded on a retroviral vector) into IMKc, subjecting these cells to cloning by limiting dilution, expanding the lacZ expressing IMKc clones, seeding them on a physiologic dermal substrate (de-epidermized human dermis, DEHD), and transplanting this tissue construct to athymic mice. These constructs were harvested and assessed for transgene expression and morphology at 4 and 6 wk after transplantation. Analysis shows these IMKc form an epidermis that is indistinguishable from an epidermis formed from nonimmortalized keratinocytes. In Kc -transduction with lacZ The amphotropic packaging cell line (Ψ-CRIP) producing α-SCG-lacZ virus (Dhawan et al, 1991) was grown to near confluence in Dulbecco's modified Eagle's medium with 10% bovine calf serum, washed with phosphate-buffered saline (PBS), and replaced with KGM. Virus containing KGM was harvested 18 h later, filtered through a 0.45 µm filter, and frozen in 5 ml aliquots at -70°C.
The IMKc were grown to µ50% confluence before transduction with the supernatants containing lacZ virus. Flasks containing IMKc were washed with PBS, and 2 ml of KGM containing lacZ virus was added to each flask along with Polybrene, 4 µg per ml. Flasks were incubated at 37°C, swirling every 30 min; after 2 h the medium was replaced with fresh KGM, cells were returned to the 37°C incubator, fed every other day with new medium, harvested, and expanded when 90%-95% confluent. A small portion of the cells was fixed with 0.5% glutaraldehyde in PBS for 10 min at room temperature and stained for lacZ expression with X-gal (Dannengerg and Suga, 1981) . Approximately 40% of the cells expressed lacZ.
Kc -cloning of IMKc transduced with lacZ
The lacZ transduced IMKc were cloned by limiting dilution (1 cell per well in 24 well plates). Each clone was grown to near confluence and harvested; 90% of the cells were transferred to a 35 mm tissue culture dish, and 10% were placed in a well of a 96 well plate. These wells were analyzed for lacZ expression using X-gal (Dannengerg and Suga, 1981) and lacZ positive clones (IMKc.T.lacZ.c) were selected. The cells expressing the transgene in the corresponding 35 mm tissue culture dish were expanded, harvested into sterile bovine calf serum with 10% dimethylsulfoxide, placed in vials (1 ϫ 10 6 per vial), and cryopreserved. This second transduction and expansion took the IMKc through additional passages and cell doublings.
Physiologic dermal substrate -source and seeding with IMKc Skin from elective abdominoplasty surgery was dermatomed with a Paget keratome to a thickness of 0.5 mm, cut into 1.5 ϫ 1.5 cm 2 squares, and subjected to three rapid freeze-thaw cycles in liquid nitrogen. This skin was placed in PBS with gentamycin (100 µg per ml), ciprofloxacin (10 µg per ml), penicillin (50 IU per ml), streptomycin (50 µg per ml), and amphotericin B (1 µg per ml), and incubated at 37°C for 3-4 d, at which time the epidermis was peeled away from the dermis. Histologic analysis revealed no viable cells and no remaining epidermis. The DEHD was stored, papillary dermis side up, in autoclaved foil at -70°C.
To seed the DEHD with IMKc, pieces of DEHD were thawed, placed papillary side up in 60 ϫ 20 mm Petri dishes (1 DEHD per dish), and 1 ϫ 10 6 normal Kc, IMKc, or IMKc.T.lacZ.c in 50-100 µl of KGM were pipetted onto the surface of the DEHD. Before seeding, keratinocytes were expanded to numbers sufficient for seeding; normal Kc were used after the fifth passage (µ15 cell doublings), IMKc were used after the seventeenth passage (µ51 cell doublings), and the IMKc.T.lacZ.c were used after the eighteenth passage (µ54 cell doublings). These skin constructs were incubated at 37°C for 3 h, 5 ml KGM was added (enough to cover the construct), and placed in the 37°C incubator for 24 h. The KGM was replaced with 10 ml of a medium which permits differentiation (KGM 60:40 Dulbecco's modified Eagle's medium with 10% fetal bovine serum) and proliferation, the constructs were returned to the 37°C incubator for 7-9 d, and the media was replaced every 3-4 d.
Transplantation of keratinocyte DEHD constructs to athymic mice DEHD-keratinocyte constructs (IMKc.T.lacZ,/DEHD, n ϭ 6 IMKc/DEHD, n ϭ 6, and normal Kc/DEHD, n ϭ 6) were transplanted to a total of 18 athymic mice (male CRL:CD-1 nude mice) using our previously described protocol (Medalie et al, 1996) . Prior to removing the DEHD-keratinocyte construct from the culture dish, any keratinocytes directly adjacent to the DEHD were physically removed with a needle. These keratinocytes adhere to the keratinocytes on the DEHD and can act as a tether to pull the epithelium off of the DEHD when it is lifted from the dish. The DEHD-keratinocyte constructs were placed on a fullthickness wound that was sized to fit the construct. The graft construct was anchored at each corner with a 6-0 suture through the graft, mouse skin, and underlying musculature. Antibiotic ointment was applied to a square piece of nonstick gauze, applied to the graft and secured to the surrounding mouse skin with several 6-0 sutures. The rest of the wound care and complex dressing followed our published protocol (Medalie et al, 1996) . Bandages were left in place for the duration of the experiment. The bandages were checked daily and the Coban dressing was changed when it became torn or loose. Three mice were sacrificed in each group at 4 and 6 wk, the bandages were carefully removed, and the grafts were excised and placed in PBS. One-half of each of the normal Kc-DEHD constructs and the IMKc-DEHD constructs were fixed in formalin and embedded in paraffin. The other half was embedded in OCT, frozen, and stored at -70°C. For the IMKc.T.lacZ.c-DEHD constructs, one-third were stained with X-gal (Dannengerg and Suga, 1981) and embedded in paraffin, one-third was not stained, fixed in formalin, and embedded in paraffin, and the final one-third was embedded in OCT frozen and stored at -70°C.
Immunohistochemistry To ascertain the expression of differentiation and proliferation markers in the three DEHD-keratinocyte constructs paraffin sections of each specimen were incubated with the following primary antibodies: loricrin (Berkeley, Richmond, CA), involucrin (Sigma, St. Louis, MO), cytokeratin 10, cytokeratin 14, collagen type IV, laminin, CD-29 (human β 1 -integrin), and PCNA (all from Biogenex, San Ramon, CA). Detection of binding utilized an appropriate secondary antibody and an alkaline phosphatase detection kit with fast red as the substrate (Biogenex). Slides were counter-stained with hematoxylin. Frozen sections of DEHDkeratinocyte constructs were assessed for bullous pemphigoid antigen 2 expression using an antibody purified from a patient suffering from bullous pemphigoid (generously supplied by the laboratory of Dr. John J. Zone, Department of Dermatology, University of Utah, Utah).
Cell cycle analysis, metaphase spread analysis, localization of transgenes with primed in situ labeling (PRINS) Normal Kc (passage 5), IMKc, and IMKc.T.lacZ.c (at passages later than those used to seed the DEHD µ passage 20) were submitted, on ice, as a single cell suspension (1 ϫ 10 6 cells per ml) in PBS, after fixation in cold methanol, for cell cycle analysis in the flow cytometry facility of the Huntsman Cancer Center at the University of Utah. Cycle analysis was generated with a Becton Dickinson Flow Cytometer (Becton Dickinson, San Jose, CA) with Becton Dickinson Cell Quest Software.
These same cells were also analyzed for karyotypic changes via metaphase analysis at the Cytogenetics/FISH Core Facility of the Huntsman Cancer Center at the University of Utah. Chromosomal localization of transgenes HPV16-E6/E7 and lacZ were localized using PRINS. Primers for HPV16-E6/E7 (UPLXSNH and RPLXSNH) were supplied by N. Matsunami. The upper and lower sequences for the lacZ primer, -ccaacagttgcgcagcctgaand -aattcgcgtctggccttcct-, respectively, were generated by the DNA/ peptide synthesis center at the University of Utah Health Sciences Center.
In situ hybridization with human specific DNA probe Histologic sections of grafts that contained the graft constructs and the surrounding mouse skin were subjected to the preparative protocol recommended by the company supplying the total human DNA biotin labeled probe (P5080-DG.5, supplied by Oncor, Gaithersburg, MD). Protocol was followed for hybridizing the probe and appropriate controls to the tissue sections. To detect hybridization, HRP labeled antibiotin diluted 1:1000 was added for 1 h. Signal was amplified using the protocol provided in the Tyramide Signal Amplification Kit (TSA-Indirect, New England Nuclear Life Sciences Products, Boston, MA). After washing excess TSA reagent from the slides, one drop of fast red chromogen (Biogenex, San Ramon, CA) was added and development monitored on a slide by slide basis.
RESULTS
Kc transduced with E6/E7 demonstrated prolonged survival in vitro Following G418 selection, the IMKc displayed normal doubling times with no evidence of diminished growth in vitro after more than 50 passages, and could be recovered and expanded after cryopreservation in liquid nitrogen. Furthermore, they displayed the capacity to differentiate in vitro, i.e., form islands of keratinocytes composed of germinal cells covered by differentiated keratinocytes.
The IMKc were transduced with a retrovirus encoding lacZ and cloned by limiting dilution (IMKc.T.lacZ.c). Several clones were selected: the clone expressing the lacZ transgene and utilized for the subsequent experiments has also been passaged Ͼ50 times (µ150 cell doublings), cryopreserved, recovered, and expanded further in vitro. These doubly transduced cells also demonstrated the capacity to differentiate in vitro.
Immortalized keratinocytes have an abnormal karyotype and the transgenes localize to chromosomes 9 and 10 Fluorescence-activated cell sorter analysis of the normal keratinocytes, the IMKc, and the IMKc.T.lacZ.c demonstrated no significant hypo-or hyperdiploidy. In addition, there were no differences in the cell cycle profile (G1, G2, S, and M) of the three cell sources.
Chromosome analysis of IMKc.T.lacZ.c showed a complex karyotype with abnormalities involving chromosomes X, 3, 10, 13, and 14. A translocation of the long arms of chromosomes 13 and 14 was observed and the X chromosome had extra material on the long arm that appeared to be part of the short arm of chromosome 3. In addition, a derivative chromosome 10 involving chromosomes 3 and 10 was present. These abnormalities were noted on all of the IMKc.T.lacZ.c examined in metaphase. All of the immortalized Kc that had not been transduced with the lacZ vector, i.e., the parent line for IMKc.T.lacZ.c, were noted to have the translocation of the long arms of chromosome 13 and 14, and some showed the derivative chromosome X or the derivative chromosome 10. These findings support the clonality of the IMKc.T.lacZ.c. Chromosomal analysis of the fibroblasts from this same source showed a normal male chromosome complement with none of the structural abnormalities involving chromosomes X, 3, 10, 13, and 14 seen in the IMKc.
PRINS was employed as an additional method to show clonality and to localize the site of incorporation of the two transgenes. With PRINS, the E6/E7 insert was localized to the heterochromic region of 9q12. A single fluorescent signal localized lacZ to chromosome 10 (Fig 1a, b) .
Expression of lacZ by E6/E7 keratinocytes is prolonged in vivo Non-immortalized fibroblasts stably transduced with retroviral vectors lose transgene expression in vivo, whereas immortalized murine fibroblasts do not (Krueger et al, 1994 (Krueger et al, , 1997 Petersen et al, 1995) . All reports of expression of transgenes by normal keratinocytes in vivo note significant loss of expression within 6 wk (Gerrard et al, 1993; Fenjves et al, 1994 Fenjves et al, , 1996 Fenjves et al, , 1997 Jensen et al, 1994; Stockschlader et al, 1994; Choate and Khavari, 1997a, b) . To ascertain the effect of immortalization on transgene expression by keratinocytes in vivo, an IMKc.T.lacZ clone was seeded onto the acellular dermis and transplanted to athymic mice. At 4 and 6 wk these grafts were removed and analyzed for transgene expression. Uniform expression of the transgene throughout the epidermis was seen at both time points (Fig 2) . The number of keratinocytes expressing the transgene was the same at 4 and 6 wk. Finger-like extensions of cells not expressing the transgene were noted at the edges of the grafts. To determine the origin of these transgene negative cells (human versus mouse), histologic sections were probed with a human specific DNA probe (Fig 3) . All cells expressing the transgene were human, whereas those not expressing the transgene were not. This suggests that host (mouse) keratinocytes had grown onto the acellular dermis at some graft edge sites. The presence of murine keratinocytes growing on the acellular dermis was confirmed by immunohistochemical staining for involucrin, a human specific antibody (see below).
Immortalized keratinocytes form a normal epidermis in vivo
The histology of the epidermis formed in vivo by cloned, immortalized keratinocytes grown on an acellular dermis (DEHD) was strikingly similar to that produced by normal (nonimmortalized) keratinocytes. Histologic analysis was carried out on the composite grafts of normal keratinocytes, and the IMKc.T.laZ.c composites harvested at 6 wk (Fig 4) . There were no substantive morphologic differences between the epidermis generated from the IMKc.T.lacZ.c and that generated from normal keratinocytes. Both displayed a normally differentiated epidermis and stratum corneum. No dyskeratotic keratinocytes were noted in the epidermis formed by the immortalized cells, nor was there evidence of invasion into the dermis.
This pattern of normal differentiation prompted a survey of expression of differentiation markers (keratins 10 and 14, involucrin, loricrin) and proliferation (PCNA) in the composite grafts. Expression of K10 (Fig 5) and involucrin (Fig 6) was not altered in the grafts containing immortalized keratinocytes: distribution and expression of both were identical to that generated by composite grafts comprised of normal keratinocytes. Involucrin expression in all composite grafts was less than that seen in normal skin in vivo. Also, involucrin was not expressed in areas where mouse keratinocytes occupied the DEHD, as the antibody to involucrin is human specific.
PCNA expression in grafts containing IMKc.T.lacZ.c and normal keratinocytes were identical, but higher than that seen in control split-thickness human skin grafts (data not shown).
The expression of several selected components of the cutaneous basement membrane (type IV collagen, β 1 -integrin, bullous pemphigoid antigen 2, and laminin) was also assessed in normal skin and the composite grafts. Grafts comprised of normal and immortalized keratinocytes demonstrated no differences in expression of these components. Expression of bullous pemphigoid antigen 2, laminin, and β 1 -integrin was less in reconstituted skin constructs than in normal skin, suggesting that these structural components had not completely formed in the composite grafts by 6 wk. Type IV collagen in normal skin was confined to the basement membrane and the blood vessels; however, in the composite grafts collagen was distributed in a broader band at the basement membrane (Fig 7) .
DISCUSSION
These studies suggest a number of reasons for using immortalized keratinocytes to further understand the use of keratinocytes in gene therapy. First, immortalized keratinocytes can be transduced with a second transgene and these cells can be cloned to generate progeny of an identical phenotype and genotype. These cells withstand cloning by limiting dilution which have been taken through at least 150 cell doublings. Normal keratinocytes will not withstand the pressure of this type of cloning and cannot, with the medium we used, be expanded after µ20 cell doublings. Second, fluorescence-activated cell sorter analysis reveals that the IMKc have no evidence of hyper-or hypo-diploidy and display a normal G 1 , S, G 2 , and M profile. As noted, the IMKc do have an abnormal karyotype linked to the transduction with HPV E6/E7 and subsequent selection in G418; the subsequent transduction with lacZ did not add any abnormalities to the karyotype. Because an epidermis with a normal phenotype was generated in vivo we do not know the significance of the abnormalities in the karyotype. Third, transgene expression in the IMKc is prolonged in vivo; no loss of expression was noted at the end of this 6 wk experiment. In contrast, it is our experience as well as that of all other investigators in this field that, with nonimmortalized cells, retroviral mediated transgene expression begins to diminish shortly after transfer to an in vivo setting and is usually absent by 6 wk (Gerrard et al, 1993; Fenjves et al, 1994 Fenjves et al, , 1996 Fenjves et al, , 1997 Jensen et al, 1994; Stockschlader et al, 1994; Choate and Khavari, 1997a, b) . This is true even when Ͼ99% of the keratinocytes express the transgene at the time of transfer in vivo (Choate and Khavari, 1997b) . Thus, the fact that no loss of transgene expression was seen within the 6 wk time frame is significant, and strongly supports the hypothesis that transgene expression will be sustained for longer periods of time in vivo when long-lived cells are used. Fourth, the epidermis produced by these cells appears normal and is comparable with that produced by normal keratinocytes. Markers of differentiation and basement membrane components are similar in both. Also, the epidermis formed by the immortalized cells does not demonstrate abnormal growth or invasive characteristics. The rate of growth, as measured by time to reach confluence in the growth conditions used in these experiments, of the IMKc in vitro does not differ substantively from that of normal Kc (data not presented). This is reflected in vivo; the PCNA expression in the IMKc and normal Kc composite grafts are not different.
These features generate enthusiasm for utilizing HPV16-E6/E7 immortalized human keratinocytes to correct diseases that are approachable via genetically modified keratinocytes; however, because abrogation of growth arrest signals by HPV16-E6/E7 has been associated with morphologic evidence of transformation of human keratinocytes grown on collagen rafts in vitro, a note of caution is appropriate (Demers et al, 1996) . Increasingly, it is appreciated that the interaction of epithelium with its stroma directs the development of normal as well as abnormal cellular proliferation and differentiation (Boudreau et al, 1995 (Boudreau et al, , 1996 Wilding et al, 1996; Turner et al, 1997) . Thus, it is possible that the HPV16-E6/E7 transformed human keratinocytes may have encountered messages that inhibit progression to a transformed or malignant phenotype, when seeded on a physiologic substrate (the DEHD) and transplanted into an in vivo setting with mammalian nutrients and mediators.
This report is generated from ''proof of principle'' experiments. Prior to any use of HPV16-E6/E7 immortalized keratinocytes in a clinical setting, studies on composite grafts in vivo that extend well beyond 6 wk are needed. Longer observation times will address many issues: whether tumors might ultimately develop, the latency of such tumors, the role of carcinogens, wound healing, and possible tumor development (the ''second hit'' hypothesis), as well as a further determination of the durability of transgene expression. It is appreciated that in some particularly disabling skin diseases, the risk of spontaneously developing tumors might be acceptable, e.g., in the dystrophic forms of epidermolysis bullosa. Survival of transgene expression in 100% of the human cells for 6 wk is a surprising and significant finding. It suggests that processes that lead to immortalization inhibit mechanisms that switch off transgenes inserted in the host genome by retroviral vectors in vivo, and/or inhibit in vivo apoptosis of cells that have been stably transduced ex vivo. Additional strategies for prolonging the life span of cells, such as overexpression of telomerase (Bodnar et al, 1998) , may significantly promote the clinical application of gene therapy using keratinocytes.
A criticism of these ''proof of principle'' experiments relates to not doing a meaningful control, a composite graft of normal Kc transduced with lacZ. As noted, transduced Kc will not survive the rigors of cloning by limiting dilution. We have conducted identical experiments with normal Kc transduced with lacZ where 30% of the Kc expressed the transgene after transduction. Composite grafts generated from these Kc were transplanted to nude mice. Loss of expression was dramatic: µ50% at 4 wk and Ͼ90% at 8 wk. At 8 wk isolated lacZ-expressing Kc were noted at the basement membrane with occasional columns of lacZ-expressing Kc. We interpret this to be compatible with the notion that transduction of both stem cells and transient amplifying cells were transduced in vitro and that with time in vivo the transgene expression was lost in the transient amplifying population. 1 It is also emphasized that in these experiments, which parallel the experiments reported here, there is significant and dramatic loss of transgene expression when normal human keratinocytes are used. Immunohistochemical demonstration of the expression of involucrin of transplanted normal human skin (a), early passage normal keratinocytes on the acellular dermis (b), and cloned immortalized lacZ expressing keratinocytes on the acellular dermis (c) after 6 wk of engraftment on nude mice (n ϭ 3). Binding of antibody specific to involucrin was developed with alkaline phosphatase-fast red. Scale bars: 40 µM.
The observation that cells with stem cell properties exist in cultures of keratinocytes from foreskin has recently been further delineated (Mathor et al, 1996; Kolodka et al, 1998) . Mathor et al noted that foreskin keratinocytes expressing retrovirally encoded transgenes can be cloned from individual cells using irradiated 3T3 feeder layer technology. Some clones had pronounced growth potential in vitro (Ͼ150 cell doublings); causing the authors to conclude these represented stem cells. When epidermal sheets derived from these clones were transplanted to athymic mice, however, graft failure ensued within 7 d (Mathor et al, 1996) . More recently Kolodka et al reported that µ25% of foreskin keratinocytes expressing retrovirally encoded transgenes had enhanced proliferative capacity (Ͼ30 cell doublings) in vitro. Epidermal sheets generated from keratinocytes containing this population were transplanted to athymic mice, recovered after varying time intervals, seeded at clonal density, and assessed for transgene expression. The frequency of expression after recovery was similar to that before transplant, µ25%. In agreement with our 1995 report, see above, was their observation of isolated transgene expressing cells in the germinative compartment and the observation that transduced cells gave rise to columns of transgene-expressing daughter cells. They Immunohistochemical demonstration of type IV collagen expression in transplanted normal human skin (a), early passage normal keratinocytes on the acellular dermis (b), and cloned immortalized lacZ expressing keratinocytes on the acellular dermis (c) after 6 wk of engraftment on nude mice (n ϭ 3). Binding of antibody specific to type IV collagen was developed with alkaline phosphatase-fast red and sections were counterstained with hematoxylin. Scale bars: 40 µM.
conclude that cultures of keratinocytes contained cells with longterm growth potential in vivo (Kolodka et al, 1998) .
Keratinocytes have a limited capacity to proliferate in vitro, especially in defined media with no feeder cell layer. Selected keratinocytes from foreskin or hair bulbs can undergo µ150 cell doublings when grown with feeder layers (Mathor et al, 1996; Kolodka et al, 1998) ; however, under culture conditions used in these experiments, greater than 20 cell doublings are rarely seen and they cannot be cloned. Thus, having generated a keratinocyte line, using standard immortalization protocols, that withstands the pressure of cloning and has gone through more than 150 cell doublings in our culture conditions, supports the probability that we have generated an immortalized cell line. If not immortal they are very long lived and can be used to generate large numbers of genetically modified daughter cells.
Other approaches to generating sustained transgene expression by human keratinocytes in vivo are being pursued. Investigators working with Dr. Khavari have generated a retroviral vector where the promoter and enhancer sequences of the LTR were deleted and inactivated. Transgene expression was noted in the epidermis of skin generated from Kc carrying this vector after 10 wk of transplantation to immunodeficient mice (Deng et al, 1997) . This suggests that cells expressing retroviral components may be more susceptible to apoptosis or that transgenes carrying LTR as a promoter are more readily inactivated.
The continued expression of stably integrated transgenes by immortalized keratinocytes in vivo makes it possible to further examine the use of keratinocytes in gene therapy. It will be possible to model systemic delivery of transgene products from a genetically modified epidermis. The rapid loss of transgene expression by genetically modified normal keratinocytes in vivo (Gerrard et al, 1993; Fenjves et al, 1994 Fenjves et al, , 1996 Fenjves et al, , 1997 Jensen et al, 1994; Stockschlader et al, 1994; Choate and Khavari, 1997a, b) makes it difficult to assess the pharmacokinetics of transgene expression in systems where the delivery system is deteriorating at an unknown rate.
It has recently been demonstrated that overproduction of ''natural immunosuppressants'', e.g., FasL, will prolong engraftment of foreign tissue (Lau et al, 1996; Zhang et al, 1997) . Development of an immortalized keratinocyte producing a ''natural immunosuppressant'' would allow exploration of the concept of a universal donor keratinocyte, a cell producing a local immunosuppressant and thereby escaping rejection by the immune system of the host.
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